Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.
about
Natural Polyphenols for Prevention and Treatment of CancerRole of Natural Stilbenes in the Prevention of CancerResearch progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanismsEffects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention.Biological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cellsImpact of trans-resveratrol-sulfates and -glucuronides on endothelial nitric oxide synthase activity, nitric oxide release and intracellular reactive oxygen species.The ellagic acid-derived gut microbiota metabolite, urolithin A, potentiates the anticancer effects of 5-fluorouracil chemotherapy on human colon cancer cells.In vitro and in vivo antitumoral effects of combinations of polyphenols, or polyphenols and anticancer drugs: perspectives on cancer treatmentBioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers.Herb-drug interactions: challenges and opportunities for improved predictions.Restenosis Inhibition and Re-differentiation of TGFβ/Smad3-activated Smooth Muscle Cells by Resveratrol.Importance of lipid microdomains, rafts, in absorption, delivery, and biological effects of resveratrol.Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update.Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells.Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism.Review of the Pharmacological Effects of Vitis vinifera (Grape) and its Bioactive Constituents: An Update.The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models.Resveratrol and its major sulfated conjugates are substrates of organic anion transporting polypeptides (OATPs): impact on growth of ZR-75-1 breast cancer cells.A role for peroxisome proliferator-activated receptor gamma in resveratrol-induced colon cancer cell apoptosis.Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells.Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells.Cancer Chemoprevention by Resveratrol: The p53 Tumor Suppressor Protein as a Promising Molecular Target.Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.In Vitro Glucuronidation and Sulfation of ε-Viniferin, a Resveratrol Dimer, in Humans and Rats.Metabolism and pharmacokinetics of resveratrol and pterostilbene.Cytotoxicity of Labruscol, a New Resveratrol Dimer Produced by Grapevine Cell Suspensions, on Human Skin Melanoma Cancer Cell Line HT-144.Cytotoxic, Antiangiogenic and Antitelomerase Activity of Glucosyl- and Acyl- Resveratrol Prodrugs and Resveratrol Sulfate Metabolites.Resveratrol and its metabolites inhibit pro-inflammatory effects of lipopolysaccharides in U-937 macrophages in plasma-representative concentrations.Polyphenols in Colorectal Cancer: Current State of Knowledge including Clinical Trials and Molecular Mechanism of Action.New Water-Soluble Carbamate Ester Derivatives of Resveratrol
P2860
Q26739022-A3051687-4E62-4417-AE57-69A916DA574EQ26769976-78CE3A88-427A-4421-9EAB-BCE309D6E90FQ28067369-47BDA261-8F29-4E22-B42A-DF05BCEBE4C4Q33771427-2ACC288F-C6EC-4F85-9BB8-5F04334F45EEQ33925336-A3333B4C-ABBF-4C0E-B79F-344EDDB77659Q35349414-51D7285B-3811-4695-A62F-9F4DA2627D2BQ35598535-27119A81-EA8B-41F9-B943-507D71C760B9Q35722741-CE4A5AEE-8683-4D67-9EB7-6B8AC84C4648Q36502078-F68D465C-1DB1-4B63-A554-C5041BFCAFF9Q37603890-64BA222D-2BF5-40E0-9D12-C04B4E3D9B3BQ37626055-D5A8C482-88F6-4A6F-AFA2-6C1A53922D33Q38121601-21CE35F1-E35C-4195-9CFD-213E44A3984FQ38245598-6A9EE305-F25F-404A-9BCC-69D83B184C8DQ38432718-903A38A8-F540-4836-A3A5-01F7E4267F44Q38810847-3D9FF5A4-5549-41B4-95B2-A91585200335Q38838495-D10D731D-0509-4606-BB54-EDEF0F24A5E2Q38938887-DCDBB8AB-2DAC-4B81-8C4A-276E78A414C6Q38977944-B79159DC-E692-49AB-B6EE-664B033AD8F7Q38979944-6D4CED0C-7F6A-4F93-A46D-C1D35093731AQ39090075-EAB903CC-F35A-4E4E-91B4-E91324DB911DQ39103076-84AEB02E-9F29-4CE5-A67D-F1AC9ED5A129Q39383463-69194AC3-942B-408A-A477-31DF0B83FA2DQ41092547-CA804489-A04B-4845-98B5-1E86B35B6C0DQ46372621-A2B4C01B-24FE-4972-BEE5-29AD6136C4CFQ47189418-71F5B7FB-A2A5-4026-89A7-A4326FBFF582Q48334826-75FA96B1-C2B8-42BC-85B5-46E73A775487Q54196205-68BE5695-B586-42EE-86F6-25ACC5290234Q54300097-D8A0CAC8-E221-4513-81C3-314F27797D5CQ54968761-C360C497-AD3F-4F2B-94AE-767670A82587Q57974104-086CB977-01E9-4A9F-9D77-502874E85669
P2860
Resveratrol metabolites inhibit human metastatic colon cancer cells progression and synergize with chemotherapeutic drugs to induce cell death.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Resveratrol metabolites inhibi ...... ic drugs to induce cell death.
@en
Resveratrol metabolites inhibi ...... ic drugs to induce cell death.
@nl
type
label
Resveratrol metabolites inhibi ...... ic drugs to induce cell death.
@en
Resveratrol metabolites inhibi ...... ic drugs to induce cell death.
@nl
prefLabel
Resveratrol metabolites inhibi ...... ic drugs to induce cell death.
@en
Resveratrol metabolites inhibi ...... ic drugs to induce cell death.
@nl
P2093
P2860
P356
P1476
Resveratrol metabolites inhibi ...... tic drugs to induce cell death
@en
P2093
Dominique Delmas
Emeric Limagne
Norbert Latruffe
Virginie Aires
P2860
P304
P356
10.1002/MNFR.201200766
P577
2013-03-14T00:00:00Z